These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10738506)

  • 1. [Diagnostic and therapeutic value of ambulatory post-voiding bladder ultrasound imaging in evaluating neurogenic bladder dysfunction].
    Amarenco G; Bayle B; Denys P; Lagauche D; Lapeyre E; Ismael SS
    Presse Med; 2000 Mar; 29(8):422. PubMed ID: 10738506
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
    Yamanishi T; Yasuda K; Tojo M; Hattori T; Sakakibara R; Shimazaki J
    Paraplegia; 1994 Apr; 32(4):271-6. PubMed ID: 7912822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
    Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
    J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of alpha-1 adrenergic innervation of the urinary bladder in human neurogenic vesical dysfunction.
    Vaidyanathan S; Rao MS; Sharma PL; Sachdeva NK
    Indian J Med Res; 1983 Apr; 77():529-33. PubMed ID: 6135662
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symptomatic therapy of bladder hyporeflexia in patients with multiple sclerosis].
    Stankovich EIu; Ovcharov VV; Gol'tsova NV; Klimov IuA; Afonin DV; Zolotova SN; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):135-7. PubMed ID: 19891358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herpes zoster induced reversible neurogenic bladder dysfunction. Urodynamic documentation of reversible bladder paralysis].
    Jensen FS; Walter S
    Ugeskr Laeger; 1991 Jan; 153(3):197-9. PubMed ID: 1998243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningitis-retention syndrome: first case of urodynamic follow-up.
    Tateno F; Sakakibara R; Sugiyama M; Takahashi O; Kishi M; Ogawa E; Uchiyama T; Yamamoto T; Yamanishi T; Yano H; Suzuki H
    Intern Med; 2011; 50(12):1329-32. PubMed ID: 21673471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bladder dysfunction in diabetics].
    Yamasaki H; Sasaki H; Furuta M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():546-52. PubMed ID: 15999767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs for Neurogenic Bladder Dysfunction].
    Sakakibara R; Sawai S; Ogata T
    Brain Nerve; 2023 May; 75(5):623-629. PubMed ID: 37194541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary retention].
    Takahashi R; Naito S
    Nihon Rinsho; 2013 Jun; 71(6):1024-6. PubMed ID: 23855207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of combination therapy with mirabegron for anticholinergic-resistant neurogenic bladder: videourodynamic evaluation].
    Wada N; Okazaki S; Kobayashi S; Hashizume K; Kita M; Matsumoto S; Kakizaki H
    Hinyokika Kiyo; 2015 Jan; 61(1):7-11. PubMed ID: 25656013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter placebo-controlled, double-blind trial of urapidil, an alpha-blocker, on neurogenic bladder dysfunction.
    Yamanishi T; Yasuda K; Homma Y; Kawabe K; Morita T
    Eur Urol; 1999 Jan; 35(1):45-51. PubMed ID: 9933794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seronegative myasthenia gravis with bladder dysfunction.
    Marouani I; Kraoua I; Benrhouma H; Rebai I; Rouissi A; Koubaa S; Turki I; Dziri C; Gouider-Khouja N
    Rev Neurol (Paris); 2012 Mar; 168(3):299-300. PubMed ID: 22365108
    [No Abstract]   [Full Text] [Related]  

  • 15. [Help for patients with multiple sclerosis: current diagnostic and treatment possibilities in neurogenic disorders of bladder emptying].
    Zwergel U; Wullich B; Jost WH; Zwergel T
    Dtsch Med Wochenschr; 1998 May; 123(22):707-12. PubMed ID: 9645188
    [No Abstract]   [Full Text] [Related]  

  • 16. Imidapril, an angiotensin-converting enzyme inhibitor, can reverse loss of bladder sensation.
    Sakakibara R; Yamaguchi C; Yamamoto T; Uchiyama T; Liu Z; Ito T; Awa Y; Yamamoto K; Kinou M; Hattori T
    J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1100-1. PubMed ID: 16914767
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurology and the bladder: how to assess and manage neurogenic bladder dysfunction, with particular references to the neural control of micturition].
    Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Uchiyama T; Yamamoto T
    Brain Nerve; 2014 May; 66(5):527-37. PubMed ID: 24807369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
    Maruyama O; Kawachi Y; Hanazawa K; Koizumi K; Yamashita R; Sugimura S; Honda S; Sugiyama Y; Saitoh T; Noto K
    Int J Urol; 2006 Oct; 13(10):1280-5. PubMed ID: 17010005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA; Gitlin J; Toro S; Palmer LS
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.